Wu, Lei;
Chen, Yaolong;
Ma, Yanfang;
Yang, Zifeng;
Yang, Nan;
Denga, Wenze;
Chen, Yuanbin;
Sun, Yuanyuan;
Li, Yimin;
Lin, Lin.
Influenza is a major public health problem worldwide. Mutations and resistance development make the use of antiviral therapy challenging. Chinese patent medicines are often used to treat influenza in China and well tolerable. However, the misuse of Chinese patent medicines is common. We therefore aimed t...
La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible. Esta guía pone a disposición del personal del primer, segundo y tercer nivel de atención las recomendaciones basadas en ...
The purpose of this guidance document is to inform physicians and
other health care practitioners of an increased risk of influenza
outbreaks in long-term care facilities (LTCF) during the 2014-2015
influenza season in Canada, and to provide recommendations for
adjustment to LTCF outbreak control measure...
Choi, Won Suk;
Baek, Ji Hyeon;
Seo, Yu Bin;
Kee, Sae Yoon;
Jeong, Hye Won;
Lee, Hee Young;
Eun, Byung Wook;
Choo, Eun Ju;
Lee, Jacob;
Song, Joon Young;
Wie, Seong-Heon;
Lee, Jin Soo;
Cheong, Hee Jin;
Kim, Woo Joo;
Kim, Young Keun.
Severe influenza is defined as influenza with a severe symptom or syndrome such
as respiratory distress or deceased consciousness or accompanying a severe complication such as encephalopathy or renal failure. In contrast to mild influenza, for
which patients recover mostly by ambulatory care, severe infl...
The purpose of this document is to provide a basis for advice to clinicians on the use of the currently available antivirals for patients presenting with illness due to influenza virus infection, as well their use for chemoprophylaxis. This guidance updates and replaces the recommendations published in A...
This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered....
This guidance is an update of WHO global influenza preparedness plan, the role of WHO and recommendations for national measures before and during pandemics, published by WHO in March 2005. The information and recommendations contained in this guidance document are the product of expert. In light of these...
